Merck Tbk PT

Merck Tbk PT R&D per Employee

The R&D Spending per Employee of Merck Tbk PT (MERK.JK) as of Oct 16, 2026 is 924,428.19 IDR. In the previous year, R&D Spending per Employee was 1.44 M IDR — a change of -35.84% (lower).

R&D per Employee

924,428.19IDR

YoY

-35.84%

Last updated:

R&D Spending per Employee of Merck Tbk PT is 2024 924,428.19 IDR. R&D Spending per Employee of Merck Tbk PT was 2023 1.44 M IDR. It decreases by -35.84% lower compared to the previous year.

The Merck Tbk PT R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2017
10.36 M IDR
Jan 1, 2018
3.01 M IDR
Jan 1, 2019
301,869.68 IDR
Jan 1, 2020
502,023.94 IDR
Jan 1, 2021
443,481.38 IDR
Jan 1, 2022
766,380.32 IDR
Jan 1, 2023
1.44 M IDR
Jan 1, 2024
924,428.19 IDR
The Merck Tbk PT R&D per Employee history
YEARR&D per EmployeeYoY
924,428.19IDR-35.84%
1.44 MIDR+88.01%
766,380.32IDR+72.81%
443,481.38IDR-11.66%
502,023.94IDR+66.30%
301,869.68IDR-89.97%
3.01 MIDR-70.95%
10.36 MIDR+116.21%
4.79 MIDR-37.60%
7.68 MIDR+18.34%
6.49 MIDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

R&D Spending per Employee of Merck Tbk PT is 924,428.19 IDR in 2024.

R&D Spending per Employee of Merck Tbk PT changed from 1.44 M IDR to 924,428.19 IDR, representing a -35.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's IDR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Merck Tbk PT historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Merck Tbk PT

All Key Metrics — Merck Tbk PT